Subeschar Treatment of Burn-Wound Infection

William F. McManus, Cleon W. Goodwin, Basil A. Pruitt

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Within a 24-month period, 454 patients were admitted with burns (average size, 33% of the total body surface [TBS]). Wound infection developed in 19, who subsequently were treated with subeschar antibiotics. The average burn size in those 19 patients was 63% of the TBS, with an average full-thickness injury of 47%. Five (26%) of the 19 survived, and five others died without evidence of wound infection, giving a wound clearance rate of 52.6%. The five surviving patients (average burn size, 59% TBS) underwent excision of infected tissue, with split-thickness cutaneous autograft closure of the burn wound, after the course of subeschar antibiotic infusion. All surviving patients were infected with Pseudomonas aeruginosa. Subeschar infusion of semisynthetic penicillins, therefore, is an effective adjunct in the care of the patient with Pseudomonas burn-wound infection.

Original languageEnglish (US)
Pages (from-to)291-294
Number of pages4
JournalArchives of Surgery
Issue number3
StatePublished - Mar 1983

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Subeschar Treatment of Burn-Wound Infection'. Together they form a unique fingerprint.

Cite this